Viewing Study NCT01382160


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-01-24 @ 11:52 PM
Study NCT ID: NCT01382160
Status: COMPLETED
Last Update Posted: 2025-12-22
First Post: 2010-12-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)
Sponsor: University Hospital, Tours
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fc gamma receptors polymorphisms View
None Rheumatoid arthritis View
None adalimumab View
None pharmacokinetic-pharmacodynamic relationship View
None immunogenicity View